×
TransMedics Operating Expenses 2019-2024 | TMDX
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
TransMedics operating expenses from 2019 to 2024. Operating expenses can be defined as the sum of all operating expenses for the given industry.
View More
TransMedics Operating Expenses 2019-2024 | TMDX
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
TransMedics operating expenses from 2019 to 2024. Operating expenses can be defined as the sum of all operating expenses for the given industry.
Related Stocks
Company Name
Market
Cap
Thermo Fisher Scientific (TMO)
$212.6B
Intuitive Surgical (ISRG)
$186.7B
Alcon (ALC)
$45.7B
IQVIA Holdings (IQV)
$39.5B
Edwards Lifesciences (EW)
$38.8B
IDEXX Laboratories (IDXX)
$35.5B
DexCom (DXCM)
$26.9B
Waters (WAT)
$22.9B
SONOVA HOLDING (SONVY)
$22B
STERIS (STE)
$21.3B
Hologic (HOLX)
$18.4B
Fresenius Medical Care AG KGaA (FMS)
$12.5B
Sysmex ADR (SSMXY)
$12.4B
Globus Medical (GMED)
$11.1B
Teleflex (TFX)
$9.2B
Penumbra (PEN)
$8.9B
Masimo (MASI)
$8.6B
Glaukos (GKOS)
$7.7B
PROCEPT BioRobotics (PRCT)
$5B
Integer Holdings (ITGR)
$4.5B
Inari Medical (NARI)
$3B
Veracyte (VCYT)
$2.9B
LivaNova (LIVN)
$2.8B
Nihon Kohden (NHNKY)
$2.5B
Elekta AB (EKTAY)
$2.3B
Tandem Diabetes Care (TNDM)
$2.2B
Integra LifeSciences Holdings (IART)
$2B
RxSight (RXST)
$1.9B
Alphatec Holdings (ATEC)
$1.3B
Artivion (AORT)
$1.2B